Incidence of glycopeptide hetero-intermediate Staphylococcus aureus strains in Maltese hospitals

M A Borg1, R Zerafa, D Morrison

  • 1Infection Control Unit, St Luke's Hospital, Guardamangia, Malta. michael.a.borg@gov.mt

Insights

High rates of methicillin-resistant Staphylococcus aureus do not predict reduced susceptibility to glycopeptides. This study found low incidence of hetero-intermediate glycopeptide susceptibility in Malta despite high MRSA rates.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Clinical Pharmacy

Background:

  • High prevalence of Methicillin-Resistant Staphylococcus aureus (MRSA) in Malta.
  • Glycopeptides like vancomycin and teicoplanin are critical for treating MRSA infections.
  • Emergence of glycopeptide resistance is a significant public health concern.

Purpose of the Study:

  • To investigate the incidence of hetero-intermediate glycopeptide susceptibility in Staphylococcus aureus isolates in Malta.
  • To determine if high MRSA endemicity predicts the emergence of reduced glycopeptide susceptibility.

Main Methods:

  • Screening of 454 non-repetitive S. aureus isolates using teicoplanin-supplemented agar.
  • Further characterization using Etests for Minimum Inhibitory Concentrations (MICs).
  • Genotypic analysis to confirm findings.

Main Results:

  • All isolates were susceptible to vancomycin.
  • Four isolates (0.88%) displayed teicoplanin MICs greater than 12 mg/L, indicating hetero-intermediate susceptibility.
  • High MRSA endemicity in Malta did not correlate with increased glycopeptide non-susceptibility.

Conclusions:

  • The emergence of hetero-intermediate glycopeptide susceptibility in S. aureus is low in Malta.
  • High MRSA rates are not a reliable predictor for the development of glycopeptide resistance.
  • Continued surveillance for antimicrobial resistance is crucial.

Related Concept Videos

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...